Open-source technology is an increasingly popular topic of conversation in the business world, with forward-thinking entrepreneurs around the globe recognising it as a solution set to expon
“We believe all drugs will be designed using AI by 2030.” At the AI4 Artificial Intelligence Conference in Las Vegas (ai4.io/usa), on 9th August, E
The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs ca
Research has shown that vaccine hesitancy is on the rise globally.
Matt D’Auria is a talent-centric leader who has been building and leading medical communications teams for over 20 years.
Editor's Picks
